Estimates of the number of genes of organisms with a wide range of biological complexity will emerge from genome sequencing projects, and this information will be crucial in correlating gene number with biological complexity. Computerbased annotations of the genome sequences of Saccharomyces cerevisiae, Caenorhabditis elegans and Drosophila melanogaster predict approximately 6,000, 19,000 and 13,600 genes, respectively. It is paradoxical that C. elegans contains 50% more genes than D. melanogaster and that the latter contains only twice as many genes as S. cerevisiae. However, these numbers should be considered with caution until gene predictions are verified using experimental approaches. To verify gene predictions experimentally, we amplified predicted open reading frames from a C. elegans complementary DNA library using the polymerase chain reaction, cloned them and generated an open reading frame sequence tag (OST) for each of them. In a random sample (n=1,200) of the approximately 10,00 genes predicted from the entire C. elegans genome but experimentally unverified so far, 90% of these predicted genes could be unambiguously verified by OST sequencing. When added to the list of approximately 9,500 genes previously verified by individual laboratories, by expressed sequence tag sequencing or both, our data confirm the existence of at least 19,000 protein-encoding genes in C. elegans. We suggest that ORFeome cloning coupled with OST analysis could be used to verify gene number predictions for other organisms. Furthermore, the demonstration and identification of 10,000 new genes provides a resource for comparative genomics and gene expression studies. We also discuss our findings in the context of the current debate on the human gene number.
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[14] Nearly three million messenger RNA transcripts have been catalogued by tissue origin to create one of the largest free databases for cancer gene expression analysis. Seventy different cell populations were studied by serial analysis of gene expression to provide precise gene expression levels in brain, breast, colon, ovarian and prostate cancers and corresponding normal tissues. Additionally, several model systems have been analyzed, providing insight into the genes transcriptionally regulated by fundamental oncogenic processes, such as angiogenesis, oncogene amplification and telomere maintenance. These data, digital northern displays and comparison tools for virtual experiments are made available by the Cancer Genome Anatomy Project at http://www.ncbi.nlm.nih.gov/SAGE/. Despite the many challenges inherent in applying large-scale gene expression data, we focus on two examples in which application of project data has yielded progress. First, mining this data readily provides candidate tumor markers or tumor antigens for the major tumors represented in the database. Using fluorescent real-time polymerase chain reaction and western blotting we showed that the mined tumor markers are expressed in an independent set of tumors and not in other normal tissues. Large-scale gene expression analysis may therefore provide a means for identifying therapeutic or prognostic targets. Second, analysis of a cell culture model for telomere maintenance (an important function of transformed cells) has provided insight into genes not previously implicated in this process. This example helps demonstrate that functional genomics on the basis of comprehensive gene expression analysis is a useful tool for hunting cancer-related genes.
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